98%
921
2 minutes
20
Background: Deterioration of renal function is associated with increased all-cause mortality. In renal masses larger than 4 cm, whether partial versus radical nephrectomy (PN vs. RN) might affect long-term functional outcomes is unknown. This study tested the association between PN versus RN and postoperative acute kidney injury (AKI), recovery of at least 90% of the preoperative estimated glomerular filtration rate (eGFR) at 1 year, upstaging of chronic kidney disease (CKD) one stage or more at 1 year, and eGFR decline of 45 ml/min/1.73 m or less at 1 year.
Methods: Data from 23 high-volume institutions were used. The study included only surgically treated patients with single, unilateral, localized, clinical T1b-2 renal masses. Multivariable logistic regression analyses were performed.
Results: Overall, 968 PN patients and 325 RN patients were identified. The rate of AKI was lower in the PN versus the RN patients (17% vs. 58%; p < 0.001). At 1 year after surgery, for the PN versus the RN patients, the rate for recovery of at least 90% of baseline eGFR was 51% versus 16%, the rate of CKD progression of ≥ 1 stage was 38% versus 65%, and the rate of eGFR decline of 45 ml/min/1.73 m or less was 10% versus 23% (all p < 0.001). Radical nephrectomy independently predicted AKI (odds ratio [OR], 7.61), 1-year ≥ 90% eGFR recovery (OR, 0.30), 1-year CKD upstaging (OR, 1.78), and 1-year eGFR decline of 45 ml/min/1.73 m or less (OR, 2.36) (all p ≤ 0.002).
Conclusions: For cT1b-2 masses, RN portends worse immediate and 1-year functional outcomes. When technically feasible and oncologically safe, efforts should be made to spare the kidney in case of large renal masses to avoid the hazard of glomerular function loss-related mortality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1245/s10434-024-15305-w | DOI Listing |
J Surg Case Rep
September 2025
Faculty of Medicine Ramathibodi Hospital, Chakri Naruebodindra Medical Institute, Mahidol University, Suvarnabhumi Canal Road, Bang Phli, Samut Prakan 10540, Thailand.
Dual primary malignancy is a rare but possible malignancy presentation. Here, we present two cases of synchronous renal cell cancer and colon cancer with simultaneous laparoscopic management. The first patient, a 65-year-old female, reported painless hematochezia, while the second, a 73-year-old female, complained of painful bloating and constipation, along with a palpable mass in the left lower quadrant of the abdomen.
View Article and Find Full Text PDFCancer Lett
September 2025
Fox Chase Cancer Center, Protocol Support Laboratory, 333 Cottman Ave., Philadelphia, PA, 19111, USA.
Historically, polyploid giant cancer cells (PGCCs) within tumors have been ignored as superfluous inflammatory refuse with no intrinsic clinical or biological relevance. However recently, multiple studies have described the existence PGCCs in solid tumor masses that appear to correlate with tumor progression, and can also appear in blood circulation as cancer associated macrophage like cells (CAMLs). In an effort to understand the clinical and biological role of CAMLs (i.
View Article and Find Full Text PDFAm J Kidney Dis
September 2025
Division of Kidney Disease and Hypertension, Warren Alpert Medical School of Brown University, Providence, Rhode Island. Electronic address:
The evaluation and management of renal masses, predominantly of the clear cell renal cell carcinoma subtype, have been evolving over the past several years and demanding greater attention from nephrologists. Oncologic survival of localized tumors approaches 100%, where survival is more closely tied to underlying comorbidities including chronic kidney disease (CKD). Early diagnosis and thus increasing prevalence related to incidental discovery of renal masses allows greater emphasis on nephron-sparing procedures and for residual kidney function preservation.
View Article and Find Full Text PDFIntractable Rare Dis Res
August 2025
Department of Radiology & Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada.
Renal oncocytomas are benign renal tumours characterized by a central stellate scar that are indistinguishable on CT/MR imaging from malignant chromophobe renal cell carcinomas (ChrRCCs). Renal oncocytomas and ChrRCCs can be separate entities but can also co-exist on a spectrum in hybrid oncocytic/ chromophobe tumours. In the past, invasive biopsy and pathologic diagnosis has been relied on to differentiate these lesion and direct management.
View Article and Find Full Text PDFInt J Surg Case Rep
August 2025
Urology Department, Saint Luke's Episcopal Hospital, Ponce, Puerto Rico.
Introduction And Importance: Renal angioleiomyoma is an exceptionally rare benign tumor of smooth muscle origin, often discovered incidentally and easily mistaken for other differential diagnoses on imaging.
Case Presentation: We report the case of a 34-year-old Puerto Rican woman with a history of prolactinoma treated with cabergoline, who was found to have a right renal-adrenal mass on imaging. She underwent successful laparoscopic resection.